AbbVie Reveals Positive Data for Eczema and Weight Loss Candidates

기사 요약

AbbVie Inc. (NYSE:ABBV) announced clinical trial data on Wednesday for two pipeline candidates, highlighting progress in its immunology and metabolic disease portfolios. The pharma giant shared encouraging Phase 2